SMAD2 and familial pancreatic carcinoma: In conclusion, we found that the EMP1-promoted binding of VASP and SMAD7 in pancreatic cancer promotes the activation of the TGF-β/Smads signaling pathway characterized by enhanced phosphorylation of SMAD2/3 (Fig. 8).